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Abstract
It is well known that the incidence odds ratio approximates the risk ratio when the disease of
interest is rare, but increasingly overestimates the risk ratio as the disease becomes more common.
However when assessing interaction, incidence odds ratios may not approximate risk ratios even
when the disease is rare. We use the term "distributional interaction" to refer to interaction that
appears when using incidence odds ratios that does not appear, or appears to a lesser degree, when
using risk ratios. The interpretational problems that arise from this discrepancy can have important
implications in epidemiologic research. Therefore, quantification of the relationship between the
interaction odds ratio and the interaction risk ratio is warranted.
In this paper, we provide a formula to quantify the differences between incidence odds ratios and
risk ratios when they are used to estimate effect modification on a multiplicative scale. Using this
formula, we examine the conditions under which these two estimates diverge. Furthermore, we
expand this discussion to the implications of using incidence odds ratios to assess effect
modification on an additive scale. Finally, we illustrate how distributional interaction arises and the
problems that it causes using an example from the literature.
Whenever the risk of the outcome variable is non-negligible, distributional interaction is possible.
This is true even when the disease is rare (e.g., disease risk is less than 5%). Therefore, when
assessing interaction on either an additive or multiplicative scale, caution should be taken in
interpreting interaction estimates based on incidence odds ratios.
Introduction
It is well known that the incidence odds ratio approxi-
mates the risk ratio when the disease of interest is rare, but
increasingly overestimates the risk ratio as the disease
becomes more common. Therefore, it may not be surpris-
ing that odds ratios can give the impression of effect mod-
ification when none exists among the corresponding risk
ratios. Despite this intuition, there is little formal discus-
sion of this phenomenon in the epidemiologic literature.
In what follows, we address this issue in an effort to
enhance our understanding of the influence of effect
measure selection on the interpretation of study results.
The risk ratio, which compares the probability of disease
in the exposed and unexposed, is a conceptually appeal-
ing measure of effect. A risk ratio (RR) of 2, for example,
is easily understood as a doubling of risk. This is in stark
contrast to the interpretational obscurity of the incidence
odds ratio (OR) [1]. When we use the term "incidence
odds ratio," we are referring to the OR calculated from
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data on disease status obtained at the end of the observa-
tion period. This is the type of odds ratio calculated from
fixed cohort studies and from case control studies that use
cumulative sampling methods (see endnote 1). Despite
this interpretational problem, the OR is frequently used
because of its appealing statistical properties. The inter-
pretational hurdle is overcome by treating the OR as if it
were a RR, by understanding an OR of 2, for example, as a
doubling of risk (see endnote 2). This interpretational
license is innocuous as long as the RR is reasonably small
and the probability of disease in the unexposed is reason-
ably low. Several formulas have been developed to quan-
tify the discrepancies between the RR and the OR and thus
prevent misinterpretation [2-5]. The general principle that
the OR approximates the RR under the rare disease
assumption is well known.
The implications of the "rare disease assumption" for the
interpretation of interaction (i.e., effect modification) on
the multiplicative or additive scale when using ORs have
received less attention. However, interpreting the OR as if
it were an RR can be particularly misleading when exam-
ining effect modification [6], as illustrated in the hypo-
thetical cohort study presented in Table 1. For simplicity,
we constructed this and all our examples with no con-
founding and no sampling or measurement error.
In this illustrative example, the RR for the relationship
between low aspirin intake and the presence of polyps is
the same for individuals with and without the high-risk
COX-2 genotype. That is, the RRs do not provide evidence
for effect modification on a multiplicative scale. Among
those without the high-risk genotype, for whom the inci-
dence of the disease is low, the OR is a close approxima-
tion of the RR. Among those with the high-risk genotype,
however, where the disease is common, the OR is not a
good approximation of the RR. This leads to considerable
heterogeneity of the OR that would be interpreted as evi-
dence of effect modification. Morabia et al. referred to this
discrepancy as "the interaction fallacy" [7]. However, as
Walter notes, this is not a statistical fallacy, since there is
indeed effect modification of the OR [8]. Nonetheless,
there is an interpretational fallacy if the conclusion
reached based on these results is that low aspirin intake
increases the risk (on a multiplicative scale) of polyps
more for individuals with the high-risk COX-2 genotype
than for individuals without the high-risk genotype. The
effect of the risk factor appears to differ between strata due
solely to a difference in the disease risk between strata.
That is, this artifact appears because the disease is differen-
tially distributed across strata. We therefore refer to this
phenomenon as "distributional interaction" (see endnote
3).
To avoid this interpretational problem, we need to know
the conditions under which effect modification of the OR
is likely to approximate effect modification of the RR and
when it is not. This understanding necessitates clarifica-
tion of the elements that cause this discrepancy. Although
Morabia et al. reported the existence of this phenomenon,
these elements have not been previously explicated in the
literature. Furthermore, this discussion has not been
extended to additive interaction. To address this problem,
we 1) provide a quantification of the relationship between
effect modification of the RR and the OR on both multi-
plicative and additive scales, 2) examine the sensitivity of
these relationships to variations in their determinants,
and 3) use an example from the literature to highlight the
causes and consequences of distributional interaction on
either the multiplicative or additive scale.
Analysis
Multiplicative interaction is commonly assessed by com-
paring the relative effect estimates for one risk factor
across strata of another risk factor. Heterogeneity of the
effect across strata is evidence of interaction. Here, we will
use an equivalent method of assessing multiplicative
interaction that we find more conceptually meaningful.
This notion of interaction refers to the extent to which the
joint effect of the two risk factors on disease differs from
the independent effects of both factors. The joint effect is
the effect of the presence of both factors on disease. Each
factor's independent effect is its effect in the absence of the
other factor. A comparison between the joint effect and
the product of the independent effects provides a measure
of multiplicative interaction. This calculation of
Table 1: Illustrative example: a hypothetical cohort study of the relationship between low aspirin intake and polyps among individuals 
with and without the high-risk COX-2 genotype
Individuals with high-risk COX-2 genotype Individuals without high-risk COX-2 genotype
Polyps No Polyps Polyps No Polyps
Low aspirin intake 75 25 30 70
High aspirin intake 25 75 10 90
Risk Ratio 3.0 3.0
Odds Ratio 9.0 3.9Epidemiologic Perspectives & Innovations 2005, 2:1 http://www.epi-perspectives.com/content/2/1/1
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multiplicative interaction (i.e. the ratio of the joint effect
to the product of the independent effects) using RRs is
shown below.
Throughout this paper, we refer to an interaction between
a genetic and an environmental factor, as in the example
of COX-2 genotype and aspirin in causing polyps
described above. This discussion could be extrapolated to
an interaction between any two factors (i.e. two genetic
factors, two environmental factors, etc.).
Notation
Here, G represents the genetic factor, E represents the envi-
ronmental factor and D represents the disease. All three
factors are dichotomous. For these factors, upper-case let-
ters indicate the presence of the factor and lower-case let-
ters indicate the absence of the factor. Assuming a
multiplicative scale, the causal effect of the G-E interac-
tion on D measured using RRs will be referred to as GxERR.
Similarly, the causal effect of the G-E interaction on D
measured using ORs will be referred to as the GxEOR. The
baseline risk of disease is represented by p(D|ge). This
refers to the probability of disease [p(D)] among those
who have neither the genetic nor the environmental risk
factor.
Assessment of Multiplicative Interaction
Population N is a population that underlies a hypotheti-
cal cohort study. The members of this population are cat-
egorized according to their exposure to G and E and
followed for incident disease. Because these two expo-
sures are dichotomous, individuals are classified accord-
ing to four exposure categories. This hypothetical cohort
study is illustrated in figure 1.
In this cohort study, those exposed to both G and E are
represented by N11, N10 represents the sub-population
that is exposed to G and unexposed to E, N01 corresponds
to the sub-population that is unexposed to G and exposed
to E, and N00 corresponds to the sub-population that is
unexposed to both factors. These individuals can be fur-
ther classified according to their D status. The cells labeled
a1 to d1 represent those exposed to G and the cells labeled
a2 to d2 represent those unexposed to G.
To demonstrate the calculation of the interaction between
G and E using RRs, we have organized the cells a1 to d2
into the two-by-two tables presented in figure 2a. The
joint and independent effects of G and E, and the calcula-
tion of the gene-environment interaction are shown in fig-
ure 2b. The baseline risk of disease, or the risk of disease
attributable to factors other than G and/or E, is repre-
sented by (c2 / N00). The RR for the joint effect of G and E
(RRGE) is calculated by comparing the risk of disease
among those who are exposed to both G and E to the
baseline risk. The RR for the independent effect of G
(RRGe) compares the risk of disease among those who are
exposed to G and unexposed to E to the baseline risk. Sim-
ilarly, the RR for the independent effect of E (RRgE) com-
pares the risk of disease among those who are unexposed
to G and exposed to E to the baseline risk. Using these
components, the gene-environment interaction based on
RRs (GxERR) is measured by the ratio of the joint RR to the
product of the independent RRs.
Schematic representation of study cohort Figure 1
Schematic representation of study cohort
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Assessment of multiplicative interaction using risk ratios and odds ratios Figure 2
Assessment of multiplicative interaction using risk ratios and odds ratios.
                 Joint effect      Independent effect        Independent effect 
           of G and E        of G (among e)          of E (among g) 
          D+       D-              D+       D-       D+   D- 
          GE            N11  Ge            N10                  gE      N01
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  c2     d2
  a2     b2
  c2     d2
GxERR =   = 
  a1     b1
  c2     d2
    a1/ N11
RRGE =
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Using the same notation and the two-by two tables shown
in parts a and b of figure 2, the joint and independent
effects of G and E measured by ORs can also be derived
(see figure 2c). Just as the joint and independent effects
measured by RRs are used to calculate the GxERR, the joint
and independent effects measured by ORs are used to cal-
culate the GxEOR.
Relationship between the GxERR and the GxEOR
Several algebraically equivalent formulations of the rela-
tionship between the OR and the RR have been discussed
in the literature [2-5]. This relationship can be expressed
in terms of two components – the size of the RR and the
magnitude of the baseline risk, i.e. the risk of the disease
in those who are unexposed (equation1) [4].
Similarly, the relationship between the GxEOR and the
GxERR depends in part on the magnitude of the GxERR and
the baseline risk of disease. Equation 1 can be used to cal-
culate the OR for each of the three components of the
GxERR, resulting in the ORGE, ORGe and ORgE. Conse-
quently, the relationship between the GxERR  and the
GxEOR can be described using equation 2, shown below.
A rearrangement of this formula is shown below in equa-
tion 3.
Equation 3 illustrates the factors that determine the rela-
tionship between the GxERR and the GxEOR: the size of the
GxERR, the magnitude of the baseline risk of disease, and
the strength of the independent effects.
For illustration, the data for the relationship between aspi-
rin, COX-2 genotype and polyps shown in table 1 can be
rearranged according to the three tables depicted in figure
2. In this example, the GxERR is 1 and the baseline risk of
disease (i.e. the probability of disease among individuals
without the high-risk genotype and with high aspirin
intake) is 10%. Additionally, the RR for the independent
effect of low aspirin intake (among individuals without
the high-risk genotype) is 3 (RRGe = 3), the RR for the
independent effect of the high-risk COX-2 genotype
(among those with high aspirin intake) is 2.5 (RRgE = 2.5),
and the RR for the joint effect of low aspirin intake and the
high-risk COX-2 genotype is 7.5 (RRGE = 7.5). When these
four elements are entered into equation 3, the GxEOR is
2.3.
Effect of Disease Risk on the Relationship between GxEOR 
and GxERR
In the absence of independent effects, equation 2 reduces
to equation 1. That is, the relationship between the GxEOR
and the GxERR is equivalent to the relationship between
the ORGE and the RRGE. This relationship can be fully
expressed in terms of the RRGE and the baseline risk. When
the RR is 1, the OR is also 1, regardless of the baseline risk
of disease. Similarly, when the GxERR is 1 and there are no
independent effects, the GxEOR is also 1, regardless of the
baseline risk of disease. In the absence of independent
effects, as the magnitude of the GxERR increases, the GxEOR
diverges from the GxERR. At a constant GxERR, the diver-
gence increases as the baseline risk of disease increases
and becomes appreciable as the baseline risk of disease
approaches 10%. Thus when there are no independent
effects, the relationship between the GxEOR and the GxERR
is precisely the same as the relationship between the OR
and the RR used to estimate main effects.
When there are independent effects, the relationship
between the GxEOR and GxERR is more complex. Figure 3
illustrates the situation in which the RR for each inde-
pendent effect is 2. As shown in this graph, the GxEOR is a
good approximation of the GxERR when the disease is very
rare [p(D|ge) = 1%], regardless of the magnitude of the
GxERR. However, as the baseline risk of disease
approaches 5%, the GxEOR begins to appreciably overesti-
mate the GxERR. In general, the larger the baseline risk of
disease, the worse the approximation, even at moderate
strengths of interaction. In fact, when the risk of the dis-
ease is 20%, the GxEOR indicates a strong interaction when
the RRs do not provide evidence for interaction.
Figure 4 highlights the situations in which a researcher
would reasonably conclude that there is no evidence for a
substantial multiplicative interaction based on RRs (i.e.
the GxERR ranges from 1.0 to 1.5). In this circumstance,
the GxEOR is a fair approximation to the GxERR when the
disease is very rare [p(D|ge) = 1%]. That is, a researcher
using the GxEOR would appropriately conclude that there
is no evidence for a multiplicative interaction. Here, as the
baseline risk of disease approaches 3%, the GxEOR begins
to appreciably overestimate the GxERR. For example, when
the GxERR is 1.3, the GxEOR is 2. Although this is not a large
overestimation it has important implications for interpre-
tation. A researcher may not find a GxERR of 1.3 indicative
of a substantial multiplicative interaction, but may con-
clude otherwise when the estimate is a 2. Again, the larger
the baseline risk of disease, the worse the approximation.
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When at least one of the independent effects is strong and
the risk of the disease is greater than 1%, the GxEOR is a
poor approximation to the GxERR even when the GxERR is
weak.
Implications for Assessment of Additive Interaction
The analyses we have shown so far indicate that using ORs
to assess multiplicative interaction can lead to interpreta-
tional difficulties. We have focused on multiplicative
interaction because this is the most common scale on
which interaction is assessed when ORs are used as a
measure of effect. However, the appropriate scale on
which to assess interaction has been a controversial topic
in epidemiology. Darroch [9] and Rothman and Green-
land [10] have mounted a persuasive argument for the use
of the additive scale to assess the presence of synergistic
effects. As they note, additive interaction can be expressed
in terms of RRs through the interaction contrast ratio. In
Equations 4 and 5 below, we refer to the interaction con-
trast ratio calculated with RRs and ORs as the ICRR and
ICOR, respectively.
Eq.4 ICRR = RRGE - RRGe - RRgE + 1
Eq.5 ICOR = ORGE - ORGe - OReE + 1
As seen in the assessment of multiplicative interaction
(equation 2), the three component ORs of the ICOR
formula can be replaced with the corresponding RR-OR
equivalence formula (equation 5). Consequently, the fac-
tors that determine the relationship between the GxERR
and the GxEOR are the same factors that determine the
relationship between the ICRR and the ICOR. Again, these
The effects of the baseline risk of disease [p(D|ge)] and the magnitude of the multiplicative interaction estimate based on risk  ratios (GxERR) on the multiplicative interaction estimate based on odds ratios (GxEOR) when the RR for each independent  effect is 2 (RRGe = RRgE = 2) Figure 3
The effects of the baseline risk of disease [p(D|ge)] and the magnitude of the multiplicative interaction estimate based on risk 
ratios (GxERR) on the multiplicative interaction estimate based on odds ratios (GxEOR) when the RR for each independent 
effect is 2 (RRGe = RRgE = 2).
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factors are the magnitude of the GxERR, the baseline risk of
disease and the strength of the independent effects. The
ICOR can result in the appearance of additive interaction
when none would be observed using the ICRR, or can sub-
stantially overestimate the magnitude of additive interac-
tion given by the ICRR (see figures 5 and 6).
For illustration, we use the scenario depicted in figure 6,
where the RRGe is 6, the RRgE is 2, and the baseline risk of
disease is 6%. In the absence of additive interaction, the
RRGE would be 7. The ICRR would reflect this absence of
additive interaction (equation 6).
Eq. 6 ICRR = RRGE - RRGe - RRgE + 1 = 7 - 6 - 2 + 1 = 0
However, as shown in equation 7, the ICOR would not
equal 0 and would give the appearance of interaction.
Eq. 7 ICOR = ORGE - ORGe - ORgE + 1 = 11.3 - 8.8 - 2.1 +
1.0 = 1.4
In this instance, one would reasonably interpret the
results from equation 7 as evidence of additive interaction
even though the same data using RRs (equation 6) would
give no indication of additive interaction. Therefore, the
problem of the OR overestimating the RR applies to inter-
action on the additive scale, in addition to the multiplica-
tive scale.
An example of distributional interaction from the 
literature
The discrepancy between incidence odds ratio- and risk
ratio-based estimates of interaction was noted by Li et al.
in an occupational cohort study of mutant p53 positivity,
a biomarker of genetic damage [11]. The authors reported
estimates of the multiplicative interaction between a pol-
ymorphism in a DNA repair gene, XRCC1, and exposure
to vinyl chloride. They found a multiplicative interaction
estimate based on ORs of 2.91. However, the interaction
estimate based on RRs was only 1.24 (see table 2). In a
reexamination of their data, we found that the ORs sub-
The effects of the baseline risk of disease [p(D|ge)] and the magnitude of the multiplicative interaction estimate based on risk  ratios (GxERR) on the multiplicative interaction estimate based on odds ratios (GxEOR) when the RR for the independent effect  of G is 6 (RRGe = 6) and the RR for the independent effect of E is 2 (RRgE = 2) Figure 4
The effects of the baseline risk of disease [p(D|ge)] and the magnitude of the multiplicative interaction estimate based on risk 
ratios (GxERR) on the multiplicative interaction estimate based on odds ratios (GxEOR) when the RR for the independent effect 
of G is 6 (RRGe = 6) and the RR for the independent effect of E is 2 (RRgE = 2).
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stantially overestimated the additive interaction based on
risk ratios as well. The ICRR was 0.96 (RRGE = 3.20, RRGe =
1.82, RRgE = 1.42) and the ICOR was 8.85 (ORGE = 12.00,
ORGe  = 2.50, ORgE  = 1.65). In this circumstance, the
overestimation can be attributed to the high baseline risk
of the outcome among this cohort of vinyl chloride work-
ers, 25%. These data highlight the potential for distribu-
tional interaction.
Conclusion
The incidence odds ratio is a very convenient measure of
effect with many appealing statistical properties including
estimability in a case-control study. However, when
assessing interaction, as when assessing main effects,
interpreting the incidence odds ratio as if it were a risk
ratio can be misleading. In particular, when the
interaction based on risk ratios is reasonably high and the
probability of disease among the unexposed is non-negli-
gible, the interaction based on incidence odds ratios may
diverge appreciably from the interaction based on risk
ratios. Even when the disease is rare (e.g.,. disease risk is
less than 5%), the incidence odds ratios can give the
appearance of interaction, on either the additive or
multiplicative scale, when the risk ratios would indicate
the absence of interaction.
In most situations where incidence odds ratios are used to
assess interaction, the corresponding interaction based on
risk ratios, the baseline risk of disease, and the strength of
the independent effects are unknown. Therefore, the
divergence of the interaction based on incidence odds
ratios from the interaction based on risk ratios is
unknown. The GxERR can be estimated using equation A1
(Appendix 1) if the odds ratios for the joint and independ-
ents effects (ORGE, ORGe, ORgE) are known and a valid
estimate of the baseline risk of disease [p(D|ge)] is availa-
ble. However, even when these factors can be estimated,
seemingly small errors in these estimates at critical thresh-
olds can create a false sense of security. For example, there
are circumstances as illustrated above, where a difference
The effects of the baseline risk of disease [p(D|ge)] and the magnitude of the additive interaction estimate based on risk ratios  (ICRR) on the additive interaction estimate based on odds ratios (ICOR) when the RR for each independent effect is 2 (RRGe =  RRgE = 2) Figure 5
The effects of the baseline risk of disease [p(D|ge)] and the magnitude of the additive interaction estimate based on risk ratios 
(ICRR) on the additive interaction estimate based on odds ratios (ICOR) when the RR for each independent effect is 2 (RRGe = 
RRgE = 2).
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of as little as 2 percentage points in the probability of dis-
ease differentiates a valid from an invalid assessment of
interaction using incidence odds ratios. Such small differ-
ences can easily be the result of measurement or sampling
error.
This paper provides guidelines for assessing the condi-
tions under which there may be interpretational difficul-
ties when using incidence odds ratios to assess interaction.
The first guideline, that caution must be used when the
outcome under investigation is relatively common, is con-
sistent with the well known "rare disease assumption".
Based on these analyses, there are many situations where
the baseline risks are likely to be high enough and the
interactions based on risk ratios strong enough to warrant
caution. For example, in epidemiologic studies of psychi-
atric disorders, disease risk is often above 10%. In cancer
epidemiology, when intermediate endpoints or biomark-
The effects of the baseline risk of disease [p(D|ge)] and the magnitude of the additive interaction estimate based on risk ratios  (ICRR) on the additive interaction estimate based on odds ratios (ICOR) when the RR for the independent effect of G is 6  (RRGe = 6) and the RR for the independent effect of E is 2 (RRgE = 2) Figure 6
The effects of the baseline risk of disease [p(D|ge)] and the magnitude of the additive interaction estimate based on risk ratios 
(ICRR) on the additive interaction estimate based on odds ratios (ICOR) when the RR for the independent effect of G is 6 
(RRGe = 6) and the RR for the independent effect of E is 2 (RRgE = 2).
Table 2: Example from Li et al: "A common polymorphism in XRCC1 as a biomarker of susceptibility for chemically induced genetic 
damage" [11]
Individuals with XRCC1 high-risk genotype (Gln – Gln) Individuals with XRCC1 low-risk genotype (Arg – Arg)
p53+ p53- p53+ p53-
High vinyl chloride 
exposure (>4000 ppm-yrs)
82 1 1 2 0
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Risk Ratio 1.76 1.42
Odds Ratio 4.80 1.65
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ers are of interest, outcome risks are often in the range of
30 to 50%. Under such circumstances, the equations and
figures provided in this paper could be used to estimate
the divergence between the interaction estimates based on
incidence odds ratios and the underlying risk ratios.
Regardless of design, in studies of interaction for common
outcomes, incidence odds ratios should be interpreted
with caution. The second guideline is less in line with con-
ventional epidemiologic wisdom. Even when the out-
come is rare, there are circumstances in which the
incidence odds ratios can still be quite misleading when
assessing interaction (e.g. the independent effect of the
gene is strong).
When assessing either multiplicative or additive interac-
tion using incidence odds ratios, consideration should
always be given to the validity of interpreting the odds
ratios as risk ratios. The danger of distributional interac-
tion, the appearance of interaction when using incidence
odds ratios that would not exist if risk ratios were used or
the exaggeration of the magnitude of the interaction based
on risk ratios, should always be considered.
Abbreviations
RR, risk ratio • OR, incidence odds ratio • G, genetic factor
• E, environmental factor • D, disease • GxERR, multipli-
cative gene-environment interaction estimate based on
risk ratios • GxEOR, multiplicative gene-environment
interaction estimate based on odds ratios • p(D), proba-
bility of disease • p(D|G-E-), probability of disease among
people without G and E (baseline risk of disease) • RRGE,
risk ratio for joint effect of G and E • RRGe, risk ratio for
independent effect of G • RRgE, risk ratio for independent
effect of E • ORGE, odds ratio for joint effect of G and E •
ORGe, odds ratio for independent effect of G • ORgE, odds
ratio for independent effect of E • ICRR, interaction
contrast ratio calculated with risk ratios • ICOR, interac-
tion contrast ratio calculated with odds ratios
Endnotes
1: This type of odds ratio might also be called the cumu-
lative incidence odds ratio, risk relative odds ratio, proba-
bility relative odds ratio or Cornfield's odds ratio [10,12].
The discussion in this paper only applies to this type of
odds ratio. It does not apply to odds ratios that result from
case-control studies in which controls are sampled from
everyone at risk (as in a case-cohort design). In such
designs, the odds are a constant multiple of the risk, and
their ratio is identical to the RR regardless of the rarity of
the disease. Similarly, the OR calculated from case-control
studies using incidence density sampling is equivalent to
the rate ratio regardless of disease rarity.
2: Treating the OR as an approximation of the rate ratio,
rather than the risk ratio may be preferable in many con-
texts. But the interpretation of the OR as the risk ratio is
most common in practice.
3: We were introduced to the term "distributional interac-
tion" by Dr. Stephen Ng when he was teaching epidemi-
ology at Columbia University. However, we have not been
able to locate any articles or books that use the term,
although we suspect that it may derive from Miettinen's
discussion of collapsibility. We prefer it to "interaction
fallacy" because a) it avoids the implication that the inter-
action is statistically incorrect and b) it is descriptive of the
source of the interaction. It arises from the different distri-
bution of disease across strata.
Appendix 1
If the odds ratios for the joint and independents effects
(ORGE, ORGe, ORgE) are known and data on the baseline
risk of disease [p(D|ge)] are available, the GxERR may be
estimated. Below, we provide a reformulation of equation
2 to estimate the GxERR based upon these inputs (equa-
tion A1).
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